Small bowel cancer risk in Lynch syndrome.
نویسندگان
چکیده
It is now evident that both forms of inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, are highly heterogeneous, not only at the clinical and pathogenetic level, but also in regard to time of appearance. In fact, early-and late-onset IBD are increasingly recognised as distinct entities that can be differentiated in regard to the underlying mechanism of inflammation and response to therapy, both in human patients and in experimental animal models. 1–3 While this differentiation is real, early and late IBD ostensibly result from the combined action of the same factors— that is, genetic predisposition, environmental changes and a disregulated immune response. On this background scenario, Damen and collaborators (Gut 2008;57:1480) ask the very pertinent question of what determines the development of specific effector T cells involved in early gut tissue damage: the expression of specific cell surface receptors or the production of specific cytokines by anti-gen-presenting cells? Based on the study of monocyte-derived dendritic cells from children with CD and UC, they found a clear dose response between the amount of the microbial ligands used to stimulate dendritic cells and the production if interleukin 12 (IL12) and IL23, and also found that the levels of these two cytokines varied independently of each other. They concluded that production of Th1-and Th17-inducing cytokines is independent of the type or stage of IBD, and the type of effector T cells depends on the amounts of particular microbial products and the presence of cell surface receptors for IL12 or IL23. While this conclusion is reasonable and plausible, it is also likely to be only part of the answer, considering the still numerous ''unknowns'' that afflict the investigation of IBD pathogenesis. Children with CD or UC display unique phenotypic and genetic characteristics related to early-onset disease. 4 IBD at a young age is associated with a stronger family history of IBD, CD-affected children are more likely than adults to have colonic involvement, and UC-affected children are more likely than adults to have extensive colitis. With regard to genetic predisposition, genome-wide association (GWA) scans performed to date have been almost exclusively performed in adult CD patients, and the genetic variants reported so far do not account for the entire IBD genetic risk. Thus, it seems probable that future GWA scans may identify novel genes linked to early-onset IBD, as has been the case for other early-onset conditions such as Alzheimer disease, type 2 diabetes …
منابع مشابه
Hereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome: Surveillance and Diagnostic strategies
Introduction: Hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) is an autosomal dominant genetic disease. The disease is caused by a mutation in one of four genes of the DNA mismatch repair system and increases the risk for various cancers, especially the uterine and colon cancers. The prevalence of this disease in the general population is about 1 in 500 and it causes about 2-3...
متن کاملColorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome
Background Chronic inflammatory bowel disease (IBD) and Lynch syndrome (LS) are associated with an increased risk for developing colorectal cancer (CRC). After 8-10 years of pan-ulcerative colitis (DC), the risk of CRC is 2%, increasing by 0.5-1.0% annually. LS has been associated with a 60-80% lifetime risk of CRC. It is unclear whether individuals diagnosed with both IBD and LS would have a c...
متن کاملWhat the physician needs to know about Lynch syndrome: an update.
The Lynch syndrome (hereditary nonpolyposis colorectal cancer [HNPCC]), is the most common form of hereditary colorectal cancer (CRC), accounting for 2% to 7% of all CRC cases. The next most common hereditary CRC syndrome is familial adenomatous polyposis (FAP), which accounts for less than 1% of all CRC. Lynch syndrome is of crucial clinical importance due to the fact that it predicts the life...
متن کاملDiagnosing Lynch syndrome
R isk stratification is essential for designing efficacious and cost effective colon cancer screening programmes. One of the most important risk factors for colorectal cancers (CRC) is an inherited predisposition, implicated in 20% of all cases. The spectrum of genetic susceptibility ranges from the low penetrance mutations that modestly increase the colon cancer risk (for example, I 1307K) to ...
متن کاملRisks of less common cancers in proven mutation carriers with lynch syndrome.
PURPOSE Patients with Lynch syndrome are at high risk for colon and endometrial cancer, but also at an elevated risk for other less common cancers. The purpose of this retrospective cohort study was to provide risk estimates for these less common cancers in proven carriers of pathogenic mutations in the mismatch repair (MMR) genes MLH1, MSH2, and MSH6. PATIENTS AND METHODS Data were pooled fr...
متن کاملA case of squamous cell carcinoma of the skin due to the molecularly confirmed Lynch Syndrome
Patients with Lynch Syndrome are at high risk for developing a variety of cancers including cancers of the colon or rectum, small bowel, stomach, uterus, renal pelvis, ureter, biliary tract, ovaries, brain and pancreas (N Engl J Med 348: 919-32, 2003; Gut 57:1097-101, 2008; NCCN, Inc Guideline. Ft. Washington, PA. Online Version 2.2014). Lack of MLH-1 and MSH-2 expression commonly result from g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Gut
دوره 57 11 شماره
صفحات -
تاریخ انتشار 2008